Veracyte stockholders approve 3.5 million share increase to 2023 equity incentive plan
At its June 10, 2026 annual meeting, Veracyte stockholders approved an amendment adding 3,500,000 shares to the 2023 Equity Incentive Plan, and elected all nine director nominees. Stockholders also ratified Ernst & Young LLP as the independent auditor for 2026 and approved executive compensation on an advisory basis. The larger share reserve gives the company more room to grant equity awards, and the plan vote drew 21,060,296 votes against.
Key points
- Stockholders approved adding 3,500,000 shares to the 2023 Equity Incentive Plan: 52,059,077 for, 21,060,296 against.
- All nine director nominees, including Eliav Barr and Brent Shafer, were elected to serve until the 2027 annual meeting.
- Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- The Board approved the plan amendment on April 8, 2026, subject to stockholder approval.
The filing
Written by AI on Nov 8, 2026, 1:54 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.